Enovis CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.2B | $2.1B | $1.7B | $1.6B | $1.4B |
| Cost of revenue | $902.8M | $926.9M | $716.4M | $693.7M | $648.5M |
| Gross profit | $1.3B | $1.2B | $990.8M | $869.4M | $777.7M |
| Selling, general & administrative | $1.1B | $1.0B | $830.3M | $772.9M | $665.8M |
| Research and development | $120.3M | $91.3M | $75.3M | $60.8M | $49.1M |
| Operating income | -$1.1B | -$775.7M | -$65.7M | -$71.2M | -$62.8M |
| Interest expense | $34.8M | $57.1M | $19.7M | $24.1M | $29.1M |
| Pretax income | -$1.2B | -$822.9M | -$67.1M | -$2.1M | -$121.8M |
| Income tax expense | $22.3M | $4.5M | -$13.3M | $36.1M | -$19.5M |
| Net income | -$1.2B | -$825.5M | -$33.3M | -$13.3M | $71.7M |
| Balance Sheet | |||||
| Cash and equivalents | $36.4M | $48.2M | $36.2M | $24.3M | $680.3M |
| Current assets | $1.2B | $1.1B | $896.5M | $795.0M | $2.3B |
| Total assets | $3.8B | $4.7B | $4.5B | $4.3B | $8.5B |
| Current liabilities | $598.5M | $529.0M | $369.6M | $565.2M | $1.0B |
| Total liabilities | $2.3B | $2.2B | $1.1B | $823.4M | $3.9B |
| Total debt | $1.3B | $1.3B | $480.0M | $259.5M | $2.1B |
| Stockholders' equity | $1.5B | $2.6B | $3.4B | $3.4B | $4.6B |
| Cash Flow Statement | |||||
| Cash from operations | $217.3M | $113.5M | $135.0M | -$55.9M | $356.1M |
| Depreciation and amortization | $1.3B | $927.8M | $217.1M | $203.0M | $187.0M |
| Stock-based compensation | $32.9M | $29.7M | $34.1M | $39.0M | $35.4M |
| Capital expenditure | $197.4M | $180.7M | $122.2M | $105.5M | $104.2M |
| Free cash flow | $19.9M | -$67.2M | $12.8M | -$161.3M | $251.9M |
| Share repurchases | $3.5M | $4.8M | $0 | $0 | — |
| Impairments | $1.0B | $645.0M | $0 | $0 | $1.5M |
Shares outstanding 57.6M · Free float 83.8%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.